
Katherine Fuh MD PhD
Gynecologic Oncology
Washington University, Gynecologic Oncology
Join to View Full Profile
1825 4th StFl 6San Francisco, CA 94143
Phone+1 415-353-9600
Fax+1 415-353-7657
Dr. Fuh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Gynecologic Oncology, 2009 - 2012
- Stanford Health Care-Sponsored Stanford UniversityResidency, Obstetrics and Gynecology, 2005 - 2009
- Georgetown University School of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2022 - 2026
- MO State Medical License 2013 - 2024
- IL State Medical License 2022 - 2023
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
Publications & Presentations
PubMed
- In vivo genome-wide CRISPR screens in human T cells to enhance T cell therapy for solid tumors.Qi Liu, Peixin Amy Chen, Esha Urs, Shimin Zhang, Maya M Arce
Biorxiv. 2025-09-24 - Multiomic Characterization of Pre- and Post-Neoadjuvant Chemotherapy-Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy Response.Mark C Valentine, Mary M Mullen, Emilee N Kotnik, Matthew A Powell, Premal H Thaker
Cancer Research. 2025-09-15 - 1 citationsDelay to timely treatment in locally advanced cervical cancer: insurance inequities in access to gynecologic oncology.Jessica Liang, Audrey Mvemba, Megan Swanson, I-Chow Joe Hsu, Edwin Alvarez
American Journal of Obstetrics and Gynecology. 2025-09-01
Journal Articles
- Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian CancerIan S Hagemann, Premal H Thaker, Carolyn K McCourt, Katherine C Fuh, David G Mutch, Andrea R Hagemann, Matthew A Powell, Clinical Cancer Research
- Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous CancerIan S Hagemann, Carolyn K McCourt, Matthew A Powell, Premal H Thaker, David G Mutch, Katherine C Fuh, Andrea R Hagemann, Clinical Cancer Research
Press Mentions
- Endometrial Cancer: Molecular Classification, Genetics, When to Rebiopsy, and What's New in the ResearchMarch 12th, 2025
- SGO Ways to Wellness: An Open Letter to My Former SelfJanuary 6th, 2025
- Aravive to Host Virtual KOL Event on Its Late-Stage Oncology Asset BatiraxceptMay 8th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: